BERKSHIRE HATHAWAY INC

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $24.4b
$45.4b +85.67%
$4.3b -90.47%
$81.8b +1792.46%
$43.3b -47.12%
$90.8b +109.94%
($22.1b) -124.29%
$97.1b +540.42%
$89.6b -7.81%
$67.3b -24.90%
Net Income (Loss) Attributable to Parent $24.1b
$44.9b +86.67%
$4.0b -91.05%
$81.4b +1924.79%
$42.5b -47.77%
$89.8b +111.18%
($22.8b) -125.41%
$96.2b +521.68%
$89.0b -7.51%
$67.0b -24.75%
Net Income (Loss) Attributable to Noncontrolling Interest $353.0m $413.0m $301.0m $375.0m $732.0m $1.0b $761.0m $924.0m $566.0m $292.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $24.4b $45.4b $4.3b $81.8b $43.3b $90.8b ($22.1b) $97.1b $89.6b $67.3b
Amortization of Intangible Assets $1.5b $1.5b $1.4b $1.3b $1.3b $1.3b $1.2b $1.8b $1.8b $1.7b
Depreciation $7.4b $7.7b $7.3b $7.6b $8.1b $8.3b $8.5b $12.5b $12.9b $13.5b $11.3b
Depreciation, Depletion and Amortization $8.9b $9.2b $9.8b $10.1b $10.6b $10.7b $10.9b $12.5b $12.9b $13.5b $14.0b
Deferred Income Tax Expense (Benefit) $2.7b ($24.8b) ($5.5b) $15.1b $7.4b $15.6b ($13.3b) $15.4b ($9.6b) $1.9b
Equity Method Investment, Other than Temporary Impairment $10.7b
Goodwill, Impairment Loss $10.0b $10.7b
Income (Loss) from Equity Method Investments $923.0m $2.9b ($2.2b) $1.2b $726.0m $995.0m $1.9b $2.0b $1.8b ($9.6b)
Nonoperating Income (Expense) ($22.5b) $72.6b $40.7b
Changes in operating assets and liabilities:
Receivables and originated loans ($3.3b) ($2.0b) ($3.4b) ($2.3b) ($1.6b) ($5.8b) ($5.6b) ($1.9b) $626.0m ($2.4b)
Increase (Decrease) in Inventories $4.8b ($1.4b) ($591.0m)
Unearned insurance premiums $968.0m $1.8b $1.8b $1.7b $1.6b $2.3b $1.9b $1.9b $376.0m $432.0m
Increase (Decrease) in Other Operating Assets $1.8b $2.0b $1.1b $1.7b $373.0m $1.3b $797.0m $861.0m
Other ($419.0m) ($3.7b) ($71.0m) ($1.5b) ($3.6b) $297.0m $239.0m $685.0m ($195.0m) $1.2b
Other assets ($373.0m) ($1.7b) ($1.8b) ($2.0b) ($1.1b) ($1.7b) ($373.0m) ($1.3b) ($797.0m) ($861.0m)
Other liabilities $1.7b $1.2b $2.0b $190.0m $3.4b $2.4b $2.0b $2.6b ($2.3b) $429.0m
Restricted cash, included in other assets at end of year $595.0m $629.0m $450.0m $457.0m $406.0m $522.0m $588.0m $621.0m $647.0m $692.0m
Net Cash Provided by (Used in) Operating Activities $32.5b
$45.8b +40.70%
$37.4b -18.30%
$38.7b +3.44%
$39.8b +2.81%
$39.4b -0.89%
$37.2b -5.57%
$49.2b +32.16%
$30.6b -37.82%
$46.0b +50.26%
$46.6b +1.45%
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $13.0b $11.7b $14.5b $16.0b $13.0b $13.3b $15.5b $19.4b $19.0b $20.9b ($22.4b)
Discount accretion on investments, principally U.S. Treasury Bills ($1.1b) ($5.5b) ($11.3b) ($12.0b)
Gain (Loss) on Investments $7.6b $1.4b ($22.2b) $71.1b $40.9b $77.6b ($67.6b) $74.9b $52.8b $39.1b ($2.1b)
Acquisitions of businesses, net of cash acquired ($31.4b) ($2.7b) ($3.3b) ($1.7b) ($2.5b) ($456.0m) ($10.6b) ($8.6b) ($396.0m) ($1.1b)
Acquisitions of treasury stock ($1.3b) ($4.8b) ($24.7b) ($27.1b) ($7.9b) ($9.2b) ($2.9b)
Payments to Acquire Businesses, Net of Cash Acquired $31.4b $2.7b $3.3b $1.7b $2.5b $456.0m $10.6b $8.6b $396.0m $1.1b ($10.7b)
Payments for (Proceeds from) Other Investing Activities $419.0m $3.7b $71.0m $1.5b $3.6b ($297.0m) ($239.0m) ($685.0m) $195.0m ($1.2b)
Net cash flows from investing activities ($84.3b) ($41.1b) ($32.8b) ($5.6b) ($37.8b) $29.4b ($87.6b) ($32.7b) ($10.3b) ($44.5b)
Net Cash Provided by (Used in) Investing Activities ($84.3b) ($41.1b) ($32.8b) ($5.6b) ($37.8b) $29.4b ($87.6b) ($32.7b) ($10.3b) ($44.5b) ($106.1b)
Cash flows from financing activities:
Changes in short term borrowings, net $130.0m $2.1b ($1.9b) $266.0m ($1.1b) ($624.0m) ($596.0m) $2.4b ($3.1b) $878.0m
Proceeds from borrowings $17.2b $5.7b $9.4b $13.5b $14.4b $6.9b $12.7b $7.8b $13.2b $9.2b
Repayments of borrowings ($4.7b) ($9.0b) ($11.6b) ($7.7b) ($6.5b) ($7.0b) ($3.9b) ($11.3b) ($11.9b) ($7.0b)
Payments for Repurchase of Common Stock $1.3b $4.8b $24.7b $27.1b $7.9b $9.2b $2.9b
Proceeds from (Payments for) Other Financing Activities ($121.0m) ($343.0m) ($497.0m) ($429.0m) ($695.0m) ($2.0b) ($4.1b) ($5.6b) ($793.0m)
Net cash flows from financing activities $12.8b
($1.4b) -110.93%
($5.8b) -315.74%
$730.0m +112.56%
($18.3b) -2612.88%
($28.5b) -55.41%
($1.7b) +94.17%
($14.4b) -766.73%
($10.4b) +28.08%
$2.2b +121.55%
Net Cash Provided by (Used in) Financing Activities $12.8b
($1.4b) -110.93%
($5.8b) -315.74%
$730.0m +112.56%
($18.3b) -2612.88%
($28.5b) -55.41%
($1.7b) +94.17%
($14.4b) -766.73%
($10.4b) +28.08%
$2.2b +121.55%
($763.0m) -134.17%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3.6b ($1.4b) $33.8b ($16.2b) $40.3b ($52.3b) $2.2b $9.7b $4.2b $41.0b
Cash and cash equivalents and restricted cash at the beginning of the year $28.6b $32.2b $30.8b $64.6b $48.4b $88.7b $36.4b $38.6b $48.4b $52.6b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($39.0b) $3.6b $30.8b $64.6b $48.4b $88.7b $36.4b $38.6b $48.4b $52.6b $41.0b
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($140.0m) $25.0m $92.0m $5.0m ($268.0m) $116.0m ($212.0m) $478.0m $349.0m
Increase in cash and cash equivalents and restricted cash ($39.0b) $3.6b ($1.4b) $33.8b ($16.2b) $40.3b ($52.3b) $2.2b $9.7b $4.2b
Effects of foreign currency exchange rate changes ($172.0m) $248.0m ($140.0m) $25.0m $92.0m $5.0m ($268.0m) $116.0m ($212.0m) $478.0m
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Cash and cash equivalents at the end of the year $28.0b $31.6b $30.4b $64.2b $48.0b $88.2b $35.8b $38.0b $47.7b $51.9b
Deferred charges - retroactive reinsurance $357.0m $1.3b $1.8b $769.0m $375.0m $698.0m $693.0m
Equity Securities, FV-NI, Gain (Loss) $71.2b $40.9b $77.4b ($67.0b) $71.8b $52.8b $40.0b
Equity Securities, FV-NI, Realized Gain (Loss) $291.0m $1.6b ($14.0b) $997.0m ($3.9b) $2.7b $3.5b ($18.0m)
Equity Securities, FV-NI, Unrealized Gain (Loss) ($22.7b) $69.6b $55.0b $76.4b ($63.1b) $69.1b $49.3b $40.0b
Financing Receivable, Credit Loss, Expense (Reversal) $177.0m $88.0m $124.0m $169.0m $298.0m $385.0m
Foreign Currency Transaction Gain (Loss), before Tax $2.1b
Gain (Loss) on Derivative Instruments, Net, Pretax ($300.0m) $1.5b $966.0m ($276.0m)
Goodwill $79.5b $81.3b $81.0b $81.9b $73.7b $73.9b $78.1b $84.6b $83.9b $83.1b $10.7b
Income Tax Expense (Benefit) $9.2b ($21.5b) ($321.0m) $20.9b $12.4b $20.9b ($8.5b) $23.0b $20.8b $15.2b
Income Taxes Paid, Net $4.7b $3.3b $4.4b $5.4b $5.0b $5.4b $4.2b $7.8b $28.5b $14.0b
Income taxes $4.0b ($25.0b) ($5.0b) $15.2b $7.2b $15.3b ($12.9b) $14.9b ($8.2b) $1.0b
Investment (gains) losses ($7.6b) ($1.4b) $22.2b ($71.1b) ($40.9b) ($77.6b) $67.6b ($74.9b) ($52.8b) ($39.1b)
Operating Lease, Lease Income $5.2b $6.0b $7.5b $8.4b $9.2b $10.0b
Other, principally transactions with noncontrolling interests $112.0m ($121.0m) ($343.0m) ($497.0m) ($429.0m) ($695.0m) ($2.0b) ($4.1b) ($5.6b) ($793.0m)
Purchases of U.S. Treasury Bills and fixed maturity securities ($96.6b) ($158.5b) ($141.8b) ($136.1b) ($208.4b) ($152.6b) ($183.9b) ($235.0b) ($526.8b) ($586.1b)
Purchases of equity securities ($16.5b) ($20.3b) ($43.2b) ($18.6b) ($30.2b) ($8.4b) ($67.9b) ($16.5b) ($9.2b) ($16.9b)
Redemptions and maturities of U.S. Treasury Bills and fixed maturity securities $26.2b $86.7b $113.0b $137.8b $149.7b $160.4b $66.3b $153.2b $353.5b $504.0b
Sales of U.S. Treasury Bills and fixed maturity securities $18.8b $49.3b $39.7b $15.9b $31.9b $27.2b $90.1b $52.3b $48.5b $44.8b
Sales of equity securities $18.8b $14.3b $38.8b $15.8b $33.7b $40.6b $143.4b $30.7b
Supplemental disclosure of cash flow information:
Unpaid losses and loss adjustment expenses $4.4b $25.0b $3.4b $6.1b $4.8b $4.6b $4.1b $2.6b $2.2b $3.1b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.